Bone Biologics is a medical device company focused on bone regeneration in spinal fusion. It develops a bone graft substitute product,NELL-1/DBX, an osteostimulative recombinant protein that provides target-specific control over bone regeneration. The company also provides a platform technology to the spine, trauma, and osteoporosis treatment markets.